Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as inhibition of microbial growth incubated for 1 week by MABA method
Antitubercular activity against PAS/INH/EMB/RMP-resistant Mycobacterium tuberculosis Spec.210 assessed as inhibition of microbial growth incubated for 1 week by MABA method
Antibacterial activity against Escherichia coli ATCC 25922 assessed as bacterial growth inhibition measured after 18 hrs by two-fold serial microdilution method
Antitubercular activity against INH-resistant Mycobacterium tuberculosis Spec.800 harboring InhA promoter mutation assessed as inhibition of microbial growth incubated for 1 week by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as fractional inhibitory concentration index incubated for 14 days in presence of 1/2 x MIC rifampicin by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as fractional inhibitory concentration index incubated for 14 days in presence of 1/2 x MIC isoniazid by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as fractional inhibitory concentration index incubated for 14 days in presence of 1/2 x MIC streptomycin by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as fractional inhibitory concentration index incubated for 14 days in presence of 1/2 x MIC ethambutol by MABA method
Antitubercular activity against Mycobacterium tuberculosis Spec.192 assessed as fractional inhibitory concentration index in presence of 1/2 x MIC rifampicin incubated for 14 days by MABA method
Antitubercular activity against Mycobacterium tuberculosis Spec.192 assessed as fractional inhibitory concentration index in presence of 1/2 x MIC isoniazid incubated for 14 days by MABA method
Antitubercular activity against Mycobacterium tuberculosis Spec.192 assessed as fractional inhibitory concentration index in presence of 1/2 x MIC streptomycin incubated for 14 days by MABA method
Antitubercular activity against Mycobacterium tuberculosis Spec.192 assessed as fractional inhibitory concentration index in presence of 1/2 x MIC ethambutol incubated for 14 days by MABA method
Antitubercular activity against PAS/INH/EMB/RMP-resistant Mycobacterium tuberculosis Spec.210 assessed as fractional inhibitory concentration index in presence of 1/2 x MIC rifampicin incubated for 14 days by MABA method